About SomnoMed
SomnoMed is a company based in Frisco (United States) founded in 2004. SomnoMed has completed 1 acquisition, including Strong Dental. SomnoMed offers products and services including SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, and SomnoBrux. SomnoMed operates in a competitive market with competitors including ResMed, AeroCare Holdings, ApniCure, ProSomnus and Sommetrics, among others.
- Headquarter Frisco, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Somnomed Limited
-
Annual Revenue
$72.8 M (USD)21.65as on Jun 30, 2025
-
Net Profit
-$2.26 M (USD)71.77as on Jun 30, 2025
-
EBITDA
$3.55 M (USD)0as on Jun 30, 2025
-
Latest Funding Round
$200 K (USD), Post-IPO
Jan 27, 2022
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SomnoMed
SomnoMed is a publicly listed company on the ASX with ticker symbol SOM in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SomnoMed
SomnoMed offers a comprehensive portfolio of products and services, including SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, and SomnoBrux.
Device repositions jaw to treat sleep apnea effectively.
Appliance manages snoring and improves airflow during sleep.
Flexible device for comfortable treatment of sleep disorders.
Tool prevents teeth grinding and related dental issues.
People of SomnoMed
Unlock access to complete
Funding Insights of SomnoMed
Investments & Acquisitions by SomnoMed
SomnoMed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Strong Dental.
Investment portfolio details for SomnoMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Dental sleep appliances for snoring and OSA treatment are developed.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for SomnoMed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SomnoMed
Detailed financials for SomnoMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Somnomed Comparisons
Peer comparison for SomnoMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SomnoMed
SomnoMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ResMed, AeroCare Holdings, ApniCure, ProSomnus and Sommetrics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices to treat sleep apnea and respiratory disorders
|
|
| Locked | Locked | Locked |
Provider of medical devices for obstructive respiratory diseases and sleep apnea
|
|
| Locked | Locked | Locked |
Home-use devices for sleep apnea treatment are developed and commercialized.
|
|
| Locked | Locked | Locked |
Lower jaw advancement devices for obstructive sleep apnea are developed.
|
|
| Locked | Locked | Locked |
Sommetrics is focused on diagnosing, treating and monitoring Obstructive Sleep Effect.
|
|
| Locked | Locked | Locked |
Respiratory devices including ventilators, masks, and oxygen therapy are manufactured.
|
Detailed competitors of SomnoMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Somnomed
Complete news archive for SomnoMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SomnoMed
SomnoMed was founded in 2004 and raised its 1st funding round 16 years after it was founded.
SomnoMed is headquartered in Frisco, United States. It is registered at Frisco, Texas, United States.
Annual revenue of SomnoMed is $72.8M as on Jun 30, 2025.
SomnoMed was founded in 2004 and focuses on treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. The primary product, SomnoDent, consists of FDA-cleared oral appliances designed for obstructive sleep apnea therapy. A North American office was established in 2006, with headquarters located in Frisco, United States. The company was taken public in 2004 within the medical device sector.
SomnoMed's top competitors include ResMed, BMC Medical and ProSomnus.
SomnoMed offers SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, and SomnoBrux.
Yes, SomnoMed is publicly traded on ASX under the ticker symbol SOM.
SomnoMed has made 1 acquisition, including Strong Dental.
The ticker symbol of SomnoMed is SOM on ASX.